LBD
AMGN icon

Landsberg Bennett & Dubbaneh’s Amgen AMGN Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-895
Closed -$206K – 255
2020
Q4 		$206K Buy
895
+89
+11% +$20.5K 0.03% 217
2020
Q3 		$200K Buy
+806
New +$200K 0.04% 204
2019
Q2 		– Sell
-1,941
Closed -$375K – 218
2019
Q1 		$375K Buy
1,941
+313
+19% +$59.8K 0.09% 170
2018
Q4 		$317K Buy
+1,628
New +$318K 0.12% 159

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's AMGN Position: Q1 2021 in Review

Landsberg Bennett & Dubbaneh sold out of Amgen (AMGN) in Q1 2021, closing a stake of 895 shares — an estimated $206K sold.

Landsberg Bennett & Dubbaneh first reported a position in AMGN in Q4 2018 and held it in 4 quarters. The position peaked at $375K in Q1 2019. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • Landsberg Bennett & Dubbaneh reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
  • Landsberg Bennett & Dubbaneh sold 895 Amgen shares in Q1 2021, an estimated $206K.
  • Landsberg Bennett & Dubbaneh first reported a position in Amgen in Q4 2018 and held it in 4 quarters.
  • Landsberg Bennett & Dubbaneh's Amgen position peaked at $375K in Q1 2019.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q1 2021, filed 19 Apr 2021.